Microbiome response to diet: focus on obesity and related diseases

Rev Endocr Metab Disord. 2020 Sep;21(3):369-380. doi: 10.1007/s11154-020-09572-7.

Abstract

Numerous studies in humans and animal models describe disturbances of the gut microbial ecosystem associated with adiposity and hallmarks of the metabolic syndrome, including hepatic and cardiovascular diseases. The manipulation of the microbiome, which is largely influenced by the diet, appears as an innovative therapeutic tool to prevent or control obesity and related diseases. This review describes the impact of nutrients on the gut microbiota composition and/or function and when available, the consequences on host physiology. A special emphasis is made on the contribution of bacterial-derived metabolites in the regulation of key gut functions that may explain their systemic effect.

Keywords: Metabolic disorders; Microbiota; Nutrition; Obesity.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiometabolic Risk Factors
  • Cardiovascular Diseases / diet therapy
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / microbiology
  • Diet*
  • Gastrointestinal Microbiome / drug effects
  • Gastrointestinal Microbiome / physiology*
  • Humans
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / microbiology
  • Intestines / drug effects
  • Intestines / microbiology
  • Metabolic Syndrome / diet therapy
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / microbiology
  • Nutrients / pharmacology
  • Obesity / complications
  • Obesity / diet therapy*
  • Obesity / microbiology*